CHICAGO, Nov. 27, 2017 /PRNewswire/ -- RSNA 2017 -- IMRIS and Hill-Rom (NYSE: HRC) announced that Hill-Rom's
The new surgical table system will be an essential component of the IMRIS Surgical Theatre – a suite of intraoperative imaging technologies that allow neurosurgeons to see critical anatomical detail during surgery, without moving the patient from the operating table.
The new TruSystem™ 7500 MR Neuro Surgical Table is specifically engineered for the MRI environment, integrates with the IMRIS Head Fixation portfolio, and is segmented for optimal patient positioning.
Furthermore, the multi-functional design offers the flexibility of interchangeable tops and therefore multi-disciplinary use.
"Our customers challenged us to develop a premium surgical table to be a key component of the IMRIS Surgical Theatre with the reliability and flexibility to meet the needs of current and future surgical applications," said IMRIS President and CEO Andrew Flanagan. "Our partnership with Hill-Rom Surgical Solutions leverages the reliability and advanced features of the TruSystem® Surgical Table platform together with the MR Neuro tabletop and head fixation system. This new offering will become a key part of our mission to optimize the surgical workflow."
The IMRIS Surgical Theatre features the world's only moving ceiling-mounted iMRI and iCT solution that delivers advanced imaging in the surgical environment. The images give neurosurgeons greater precision, improve patient outcomes and eliminate the risks inherent in moving a patient during a procedure.
Hill-Rom is a global leader in developing innovative technology for operating rooms and intensive care units. Rapid, smooth workflows are of life-saving importance, and its digital systems and automated intelligence solutions are becoming a standard of care in hospitals worldwide.
"We're thrilled to partner with IMRIS, to offer enhanced flexibility and efficiency for surgeons with the integration of the IMRIS Surgical Theatre and the TruSystem® 7500 MR Neuro Surgical Table," said Francisco Canal Vega, president of Hill-Rom Surgical Solutions. "Our proven reliability, ergonomic design and range of options will prove to be a valuable addition to the IMRIS portfolio, meeting the demands of the neurosurgeon and the expectations of hospital administration."
The new surgical table will be part of a limited market evaluation to understand how this new system can be best utilized to elevate the intraoperative experience. Full market launch is expected in early 2018.
As a leader in image guided therapy solutions, IMRIS offers the most advanced hybrid surgical theatres with the world's first and only moving ceiling-mounted iMRI and iCT technology that gives neurosurgeons access to high-quality image detail pre-, mid- and post-operation. With a unique symphony of engineering and advanced imaging technology, the IMRIS Surgical Theatre is built for the human experience and inspired by the human mind. IMRIS serves leading hospitals worldwide, offering optimized workflow for surgeons, maximum value for hospitals and better outcomes for patients. As part of its four-pronged business model – Consult, Design, Create and Support – each IMRIS Surgical Theatre is custom-developed for the hospital and surgeons to uniquely compliment their workflow and intended use. For more information, call 763.203.6300, email [email protected] or visit www.imris.com.
About Hill-Rom Holdings, Inc.
Hill-Rom is a leading global medical technology company with more than 10,000 employees worldwide. We partner with health care providers in more than 100 countries, across all care settings, by focusing on patient care solutions that improve clinical and economic outcomes in five core areas: Advancing Mobility, Wound Care and Prevention, Patient Monitoring and Diagnostics, Surgical Safety and Efficiency and Respiratory Health. Hill-Rom's people, products and programs work towards one mission: Every day, around the world, we enhance outcomes for patients and their caregivers. Visit www.hill-rom.com for more information.
TruSystem is a registered trademark of Trumpf GmbH + Co. KG.
For IMRIS:MediaContact: Shelli Lissick Phone: 651-276-6922Email: [email protected]
Investor RelationsContact: Mary Kay Ladone, Vice President, Investor Relations Phone: 312-819-9387Email: [email protected]
MediaContact: Howard Karesh, Vice President, Corporate Communications Phone: 312-819-7268 Email: [email protected]
View original content:http://www.prnewswire.com/news-releases/imris-and-hill-rom-announce-fda-clearance-of-new-mri-conditional-surgical-table-for-hybrid-or-300561802.html
SOURCE Hill-Rom Holdings, Inc.
Subscribe to our Free Newsletters!
Breathing in unclean air due to increasing air pollution could cause kidney damage with resultant ...
Benign prostatic hyperplasia or enlarged prostate is a noncancerous condition observed in men above ...
Urinary retention is a condition where a person is unable to voluntarily empty the urinary bladder ...View All